IDH2 and neuroendocrine carcinoma: Although we were not able to include tumors from this class in our proteomics study due to insufficient quantities of tumor tissue, we did not detect immunohistochemical expression of the neuroendocrine and neuronal markers that were upregulated in NEC-like IDH2 and NEC-like SMARCA4/ARID1A tumors.